Mediation of movement-induced breakthrough cancer pain by IB4-binding nociceptors in rats

Joshua Havelin, Ian Imbert, Devki Sukhtankar, Bethany Remeniuk, Ian Pelletier, Jonathan Gentry, Alec Okun, Timothy Tiutan, Frank Porreca, Tamara E. King

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Cancer-induced bone pain is characterized by moderate to severe ongoing pain that commonly requires the use of opiates. Even when ongoing pain is well controlled, patients can suffer breakthrough pain (BTP), episodic severe pain that “breaks through” the medication. We developed a novel model of cancer-induced BTP using female rats with mammary adenocarcinoma cells sealed within the tibia. We demonstrated previously that rats with bone cancer learn to prefer a context paired with saphenous nerve block to elicit pain relief (i.e., conditioned place preference, CPP), revealing the presence of ongoing pain. Treatment with systemic morphine abolished CPP to saphenous nerve block, demonstrating control of ongoing pain. Here, we show that pairing BTP induced by experimenter-induced movement of the tumor-bearing hindlimb with a context produces conditioned place avoidance (CPA) in rats treated with morphine to control ongoing pain, consistent with clinical observation of BTP. Preventing movement-induced afferent input by saphenous nerve block before, but not after, hindlimb movement blocked movement-induced BTP. Ablation of isolectin B4 (IB4)-binding, but not TRPV1>, sensory afferents eliminated movement-induced BTP, suggesting that input from IB4-binding fibers mediates BTP. Identification of potential molecular targets specific to this population of fibers may allow for the development of peripherally restricted analgesics that control BTP and improve quality of life in patients with skeletal metastases.

Original languageEnglish (US)
Pages (from-to)5111-5122
Number of pages12
JournalJournal of Neuroscience
Volume37
Issue number20
DOIs
StatePublished - May 17 2017

Fingerprint

Breakthrough Pain
Nociceptors
Lectins
Pain
Nerve Block
Bone Neoplasms
Hindlimb
Morphine
Opiate Alkaloids
Cancer Pain
Tibia
Analgesics
Neoplasms
Adenocarcinoma
Breast
Quality of Life
Observation
Neoplasm Metastasis

Keywords

  • Breakthrough pain
  • C-fiber
  • Cancer pain
  • IB4
  • Nonpeptidergic
  • Peptidergic

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Havelin, J., Imbert, I., Sukhtankar, D., Remeniuk, B., Pelletier, I., Gentry, J., ... King, T. E. (2017). Mediation of movement-induced breakthrough cancer pain by IB4-binding nociceptors in rats. Journal of Neuroscience, 37(20), 5111-5122. https://doi.org/10.1523/JNEUROSCI.1212-16.2017

Mediation of movement-induced breakthrough cancer pain by IB4-binding nociceptors in rats. / Havelin, Joshua; Imbert, Ian; Sukhtankar, Devki; Remeniuk, Bethany; Pelletier, Ian; Gentry, Jonathan; Okun, Alec; Tiutan, Timothy; Porreca, Frank; King, Tamara E.

In: Journal of Neuroscience, Vol. 37, No. 20, 17.05.2017, p. 5111-5122.

Research output: Contribution to journalArticle

Havelin, J, Imbert, I, Sukhtankar, D, Remeniuk, B, Pelletier, I, Gentry, J, Okun, A, Tiutan, T, Porreca, F & King, TE 2017, 'Mediation of movement-induced breakthrough cancer pain by IB4-binding nociceptors in rats', Journal of Neuroscience, vol. 37, no. 20, pp. 5111-5122. https://doi.org/10.1523/JNEUROSCI.1212-16.2017
Havelin J, Imbert I, Sukhtankar D, Remeniuk B, Pelletier I, Gentry J et al. Mediation of movement-induced breakthrough cancer pain by IB4-binding nociceptors in rats. Journal of Neuroscience. 2017 May 17;37(20):5111-5122. https://doi.org/10.1523/JNEUROSCI.1212-16.2017
Havelin, Joshua ; Imbert, Ian ; Sukhtankar, Devki ; Remeniuk, Bethany ; Pelletier, Ian ; Gentry, Jonathan ; Okun, Alec ; Tiutan, Timothy ; Porreca, Frank ; King, Tamara E. / Mediation of movement-induced breakthrough cancer pain by IB4-binding nociceptors in rats. In: Journal of Neuroscience. 2017 ; Vol. 37, No. 20. pp. 5111-5122.
@article{7d1bb0906e744a3892178d202ea0b4ca,
title = "Mediation of movement-induced breakthrough cancer pain by IB4-binding nociceptors in rats",
abstract = "Cancer-induced bone pain is characterized by moderate to severe ongoing pain that commonly requires the use of opiates. Even when ongoing pain is well controlled, patients can suffer breakthrough pain (BTP), episodic severe pain that “breaks through” the medication. We developed a novel model of cancer-induced BTP using female rats with mammary adenocarcinoma cells sealed within the tibia. We demonstrated previously that rats with bone cancer learn to prefer a context paired with saphenous nerve block to elicit pain relief (i.e., conditioned place preference, CPP), revealing the presence of ongoing pain. Treatment with systemic morphine abolished CPP to saphenous nerve block, demonstrating control of ongoing pain. Here, we show that pairing BTP induced by experimenter-induced movement of the tumor-bearing hindlimb with a context produces conditioned place avoidance (CPA) in rats treated with morphine to control ongoing pain, consistent with clinical observation of BTP. Preventing movement-induced afferent input by saphenous nerve block before, but not after, hindlimb movement blocked movement-induced BTP. Ablation of isolectin B4 (IB4)-binding, but not TRPV1>, sensory afferents eliminated movement-induced BTP, suggesting that input from IB4-binding fibers mediates BTP. Identification of potential molecular targets specific to this population of fibers may allow for the development of peripherally restricted analgesics that control BTP and improve quality of life in patients with skeletal metastases.",
keywords = "Breakthrough pain, C-fiber, Cancer pain, IB4, Nonpeptidergic, Peptidergic",
author = "Joshua Havelin and Ian Imbert and Devki Sukhtankar and Bethany Remeniuk and Ian Pelletier and Jonathan Gentry and Alec Okun and Timothy Tiutan and Frank Porreca and King, {Tamara E.}",
year = "2017",
month = "5",
day = "17",
doi = "10.1523/JNEUROSCI.1212-16.2017",
language = "English (US)",
volume = "37",
pages = "5111--5122",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "20",

}

TY - JOUR

T1 - Mediation of movement-induced breakthrough cancer pain by IB4-binding nociceptors in rats

AU - Havelin, Joshua

AU - Imbert, Ian

AU - Sukhtankar, Devki

AU - Remeniuk, Bethany

AU - Pelletier, Ian

AU - Gentry, Jonathan

AU - Okun, Alec

AU - Tiutan, Timothy

AU - Porreca, Frank

AU - King, Tamara E.

PY - 2017/5/17

Y1 - 2017/5/17

N2 - Cancer-induced bone pain is characterized by moderate to severe ongoing pain that commonly requires the use of opiates. Even when ongoing pain is well controlled, patients can suffer breakthrough pain (BTP), episodic severe pain that “breaks through” the medication. We developed a novel model of cancer-induced BTP using female rats with mammary adenocarcinoma cells sealed within the tibia. We demonstrated previously that rats with bone cancer learn to prefer a context paired with saphenous nerve block to elicit pain relief (i.e., conditioned place preference, CPP), revealing the presence of ongoing pain. Treatment with systemic morphine abolished CPP to saphenous nerve block, demonstrating control of ongoing pain. Here, we show that pairing BTP induced by experimenter-induced movement of the tumor-bearing hindlimb with a context produces conditioned place avoidance (CPA) in rats treated with morphine to control ongoing pain, consistent with clinical observation of BTP. Preventing movement-induced afferent input by saphenous nerve block before, but not after, hindlimb movement blocked movement-induced BTP. Ablation of isolectin B4 (IB4)-binding, but not TRPV1>, sensory afferents eliminated movement-induced BTP, suggesting that input from IB4-binding fibers mediates BTP. Identification of potential molecular targets specific to this population of fibers may allow for the development of peripherally restricted analgesics that control BTP and improve quality of life in patients with skeletal metastases.

AB - Cancer-induced bone pain is characterized by moderate to severe ongoing pain that commonly requires the use of opiates. Even when ongoing pain is well controlled, patients can suffer breakthrough pain (BTP), episodic severe pain that “breaks through” the medication. We developed a novel model of cancer-induced BTP using female rats with mammary adenocarcinoma cells sealed within the tibia. We demonstrated previously that rats with bone cancer learn to prefer a context paired with saphenous nerve block to elicit pain relief (i.e., conditioned place preference, CPP), revealing the presence of ongoing pain. Treatment with systemic morphine abolished CPP to saphenous nerve block, demonstrating control of ongoing pain. Here, we show that pairing BTP induced by experimenter-induced movement of the tumor-bearing hindlimb with a context produces conditioned place avoidance (CPA) in rats treated with morphine to control ongoing pain, consistent with clinical observation of BTP. Preventing movement-induced afferent input by saphenous nerve block before, but not after, hindlimb movement blocked movement-induced BTP. Ablation of isolectin B4 (IB4)-binding, but not TRPV1>, sensory afferents eliminated movement-induced BTP, suggesting that input from IB4-binding fibers mediates BTP. Identification of potential molecular targets specific to this population of fibers may allow for the development of peripherally restricted analgesics that control BTP and improve quality of life in patients with skeletal metastases.

KW - Breakthrough pain

KW - C-fiber

KW - Cancer pain

KW - IB4

KW - Nonpeptidergic

KW - Peptidergic

UR - http://www.scopus.com/inward/record.url?scp=85019951587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019951587&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.1212-16.2017

DO - 10.1523/JNEUROSCI.1212-16.2017

M3 - Article

C2 - 28438966

AN - SCOPUS:85019951587

VL - 37

SP - 5111

EP - 5122

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 20

ER -